HF
CO

HRT Financial’s Global Cord Blood Corporation CO Stock Holding History

HRT Financial’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,051
Closed -$58K – 4251
2021
Q4 		$58K Sell
14,051
-9,317
-40% -$39.6K ﹤0.01% 2826
2021
Q3 		$109K Buy
23,368
+1,629
+7% +$7.99K ﹤0.01% 2878
2021
Q2 		$116K Sell
21,739
-17,325
-44% -$90.7K ﹤0.01% 2560
2021
Q1 		$176K Buy
+39,064
New +$169K ﹤0.01% 2346
2019
Q4 		– Sell
-14,706
Closed -$71K – 1910
2019
Q3 		$71K Buy
+14,706
New +$77.1K ﹤0.01% 1277

Other funds holding CO

OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

HRT Financial's CO Position: Q1 2022 in Review

HRT Financial sold out of Global Cord Blood Corporation (CO) in Q1 2022, closing a stake of 14,051 shares — an estimated $58K sold.

HRT Financial first reported a position in CO in Q3 2019 and held it in 5 quarters. The position peaked at $176K in Q1 2021. 29 funds tracked by Wall St. Rank hold CO as of Q1 2022.

  • HRT Financial reported no remaining Global Cord Blood Corporation position as of Q1 2022 after selling out during the quarter.
  • HRT Financial sold 14,051 Global Cord Blood Corporation shares in Q1 2022, an estimated $58K.
  • HRT Financial first reported a position in Global Cord Blood Corporation in Q3 2019 and held it in 5 quarters.
  • HRT Financial's Global Cord Blood Corporation position peaked at $176K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q1 2022.

Based on HRT Financial's 13F filing for Q1 2022, filed 16 May 2022.